Stocks need to hold any gains after the Fed rate cut or the S&P 500 is at risk | news.google.com • |
What's Next After FOMC's Aggressive Interest Rate Cuts? | marketbeat.com • |
Priyanka Chopra Returns To Citadel Spy-Verse, Shares New Post: "Nadia Is Back" | news.google.com • |
Citadel Season 2: Priyanka Chopra Shares Glimpse From The Sets of Spy Series | news.google.com • |
20 S&P 500 Stocks That Move The Most When The Fed Starts Cutting Interest Rates | news.google.com • |
Fed Day: 5 Things Investors Need to Know for FOMC Meeting | zacks.com • |
Dividend | Date |
---|---|
1.75902 | 2024-06-21 |
1.59494 | 2024-03-15 |
1.90607 | 2023-12-15 |
1.58317 | 2023-09-15 |
1.63837 | 2023-06-16 |
1.5062 | 2023-03-17 |
-
If we had an African Mooslem Puppet President we could make China happy
Or maybe just sleepy Joe -
$SAVA - A second opinion
*
If you have been following Cassava and their Alzheimers drug PTI-125, you will know that 1 of 2 trial endpoints was not recently met, sending the stock down almost 80%. But, I think the exodus was premature. Here is why:Per the companys press release, one endpoint WAS MET:
A secondary endpoint of CSF levels of IL1-beta, a core biomarker of neuroinflammation from baseline to day 28, was met, Cassava said. The drug was also found to be safe and well-tolerated.Per NIH, neuro inflammation is the CORE issue with Alzheimers:
Inflammation in Alzheimer's disease (AD) has emerged as a central pathology that likely plays a role in onset and progression of the disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214864/Cycling back to Cassavas press release, they state:
CSF levels of IL1-beta, a core biomarker of neuroinflammation ... was met
To reiterate the NIH definition, Neuro Inflammation is core to the onset and progression of Alzheimers. At some point, Cassava IS going to cycle back around to the secondary endpoint (neuro inflammation), and realize that ALONE constitutes an ALZHEIMER DRUG THAT WORKS.
In this case, traders were SO tuned into the word miss that they MISSED something EXTREMELY IMPORTANT -> The efficacy of PTI-125 towards Neuro Inflammation, in Alzheimers (ALONE), makes it A BLOCKBUSTER DRUG!
-
-
Sleepy Joe is the perfect puppet to make China happy
-
Maybe if we get another African Mooslem puppet President, everything will be ok
At least we can make China happy -
The Jew Jim Cramer, pumping China on CNBC.
He Lives China and Pelosi -
Did someone just say New York Lotto is offering Mega Millions? Or maybe I might’ve heard Wall street is offering Mega Millions?
-
-
-
-
-
-
-
$SPY Shorts will be the fuel for this last rally to 300 keep shorting please thanks
-
Sell this shit
-
You stewed sell
-
Shit in s going down like it or not if not your a big h
-
What's Next After FOMC's Aggressive Interest Rate Cuts?
marketbeat.com • -
SPY: Equity And Bond Markets Flash Conflicting Signals On Recession Risk
seekingalpha.com • -
SPY: 3 Paths for Stocks AFTER Fed Meeting
news.google.com • -
New Gamma ETF Mixes Large-Cap & T-Bill Exposure
etftrends.com • -
Market Internals Signal Upside Breakout
forbes.com • -
SPY ETF Update, 9/17/2024
news.google.com • -
5 Stocks That Led the SPY ETF to Log Its Best Week in 2024
news.google.com • -
S&P 500 Snapshot: Market Bounces Back
etftrends.com • -
(SPY) Pivots Trading Plans and Risk Controls
news.google.com • -
SPY: The Market May Be Wrong Now
seekingalpha.com • -
What VIX Tells Us About Opportunity in Low Vol ETFs
etftrends.com • -
S&P 500 Snapshot: Market Bounces Back- Advisor Perspectives
news.google.com • -
SPY: CPI Tailwinds Already Priced In
seekingalpha.com • -
Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
marketbeat.com • -
These 2 REITs Are Still Great Buys After The Real Estate Rally
seekingalpha.com • -
If You Can Only Buy One Stock, It Better Be One of These 3 Names
247wallst.com • -
2 Very Overrated And 2 Very Underrated Big Dividend Funds
seekingalpha.com • -
Dividend Histories Help
seekingalpha.com •